my account
Login
  Loading... Please wait...

Product Details

Ruxolitinib | JAK inhibitor

Ruxolitinib (941678-49-5) is an ATP-competitive inhibitor of Janus-associated kinase 1 and 2. (IC50's of 2.7, 4.5 and 322 nm for JAK1, JAK2 and JAK3 respectively).1,2 Clinically useful cancer chemotherapeutic.

References/Citations
1) Verstovsek et al. (2009), Therapeutic potential of JAK2 inhibitors; Hematology Am. Soc. Hematol. Educ. Program, 2009(1) 636
2) Quintas-Cardama et al. (2010), Preclinical characterization of the selective JAK1/2 inhibitor INCB01824: Therapeutic implications for the treatment of myeloproliferative neoplasms; Blood, 115 3109

swipe
Image 1

Catalog#  10-4511

$90.00
Quantity
Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee.
 
Request Bulk Quote
CAS:
941678-49-5
Catalog Number:
10-4511
Activity:
JAK inhibitor
Alternate Names:
INCB 018424
Chemical Name:
βR-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile
Molecular Weight:
306.37
Molecular Formula:
C17H18N6
Solubility:
Soluble in DMSO (up to 5 mg/ml) or in Ethanol (up to 10 mg/ml).
Physical Properties:
White solid
Purity:
99% by HPLC
NMR (Conforms)
Storage Temperature:
-20°
Stability:
Stable for 1 year as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months.
Shipping Code:
RT
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications.

Share Focus

Connect with Focus

Click the button below to add the Ruxolitinib | JAK inhibitor to your wish list.